Free Trial

Hypera (OTCMKTS:HYPMY) Stock Price Passes Above 50 Day Moving Average - Time to Sell?

Hypera logo with Medical background

Hypera S.A. (OTCMKTS:HYPMY - Get Free Report)'s share price crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $3.96 and traded as high as $4.91. Hypera shares last traded at $4.91, with a volume of 706 shares.

Hypera Stock Down 5.5%

The company has a debt-to-equity ratio of 0.68, a current ratio of 1.81 and a quick ratio of 1.41. The firm has a 50 day simple moving average of $4.04 and a 200-day simple moving average of $3.50. The stock has a market capitalization of $2.94 billion, a price-to-earnings ratio of 19.33 and a beta of 0.79.

Hypera (OTCMKTS:HYPMY - Get Free Report) last released its quarterly earnings data on Wednesday, April 23rd. The company reported ($0.04) earnings per share (EPS) for the quarter. Hypera had a return on equity of 13.18% and a net margin of 20.04%. The company had revenue of $184.34 million for the quarter.

Hypera Company Profile

(Get Free Report)

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.

Featured Stories

Should You Invest $1,000 in Hypermarcas Right Now?

Before you consider Hypermarcas, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hypermarcas wasn't on the list.

While Hypermarcas currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead
3 Made in America Stocks Under $20 You Need to See!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines